Covidien to Present at Upcoming Investor Conferences

Business Wirevia The Motley Fool
Updated

Covidien to Present at Upcoming Investor Conferences

MANSFIELD, Mass.--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, today announced that Charles J. Dockendorff, Executive Vice President and Chief Financial Officer, will represent the Company at two upcoming conferences:

Citi 2013 Global Health Care Conference
February 26, 2013 - New York, NY
3:00PM ET


RBC Capital Markets Healthcare Conference
February 27, 2013 - New York, NY
11:00AM ET

A live audio webcast of the presentations can be accessed at Covidien's Investor Relations website: http://investor.covidien.com.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.



Covidien
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com

KEYWORDS: United States North America Massachusetts New York

INDUSTRY KEYWORDS:

The article Covidien to Present at Upcoming Investor Conferences originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement